Gençler Arasındaki Popüler Psikoaktif Madde; Sentetik Kannabinoid (bonzai): Bir Gözden Geçirme

Ba?ymlylyk, insanlaryn sa?lyk ve sosyal ya?amlaryny olumsuz etkilemesine ra?men bir nesneye veya ki?iye duyulankontrol edilemeyen istek duygusudur. Günümüzde,dünyadaki ço?u ülkeyi ciddi bir ?ekilde tehdit eden ve enfazla tarty?ylan ba?ymlylyk çe?idi, psikoaktif madde ba?ymlyly?ydyr. Bu kategoride bulunan ve insanlar arasyndagenellikle bonzai olarak bilinen popüler madde, özelliklegençlerin sa?lyklaryny ve sosyal ya?amlaryny kötü ?ekildeetkilemektedir. Kullanymynyn arty? göstermesi ve halksa?ly?yna kar?y bir tehdit olu?turmasy ile bu madde, sa?lykdünyasynda önemli derecede dikkat çekmi?tir. Dünyadave Türkiye'de özellikle son zamanlarda syklykla kullanylanbonzai, "yeni nesil" sentetik kannabinoid (SK) olarakisimlendirilmektedir. Birçok ara?tyrma verilerine göre son10 yylda özellikle gençler arasynda bir psikoaktif maddeolan sentetik kannabinoid maddesinin kullanymynyn hyzlybir ?ekilde artty?y anla?ylmy?tyr. Kannabis (örne?in, marihuana) ile benzer etkiler gösterdi?i inancy insanlar arasynda çok yaygyndyr. Fakat bazy benzer etkiler göstermelerinera?men, sentetik kannabinoid'in yapysyndaki kimyasaleklentiler bu maddeyi çok tehlikeli kylmy?tyr. Bu çaly?ma,özellikle gençler tarafyndan kötüye kullanylan ve hyzly bir?ekilde ba?ymlylyk geli?tirebilen sentetik kannabinoid(bonzai) maddesini ele alan bir derleme çaly?masydyr.Çaly?manyn amacy, son zamanlarda özellikle gençleritehdit eden sentetik kannabinoidlerin hyzla yayylmanedenlerini anlamak, kullanycylar üzerindeki etkileriincelemek ve kullanym sykly?y hakkynda bilgilendirmektir.

A Popular Psychoactive Substance Among Youth; Synthetic Cannabinoid (bonsai): A Review

Addiction refers to not being able to control over desiretowards an object or someone even though it has negative impact on one's health and social life. Nowadays,psychoactive drug use has become very serious issue forpeople. Since it threatens most of the countries in theworld, many researchers have focused on psychoactivedrugs. Bonsai is popular substance in this category. Thissubstance is known as bonsai among public whichaffects health and social life of teenage and youngadults negatively. Since it has become a threat for publichealth, this psychoactive drug has attracted notice significantly in short time. This drug is entitled as "new generation" snythetic cannabinoid and recently, it has beenused very frequently in all around the world includingTurkey. Findings from various research have indicatedthat the use of synthetic cannabinoid (bonsai) hasincreased dramatically among youth in last 10 years.People generally think that synthetic cannabinoid (bonsai) has very similar effect with cannabis (i.e. marijuana).Although they show some similar effects, syntheticcannabinoid (bonsai) is very dangerous since it haschemical additions. It is also known that person who usethis drug can develop substance addiction rapidly. Thisreview study has focused on synthetic cannabinoid (bonsai) which is commonly abused by youth. The aim of thisstudy is therefore, to understand the reasons of theincrease in the usage; to examine the negative impactsand to consider the prevalence of the synthetic cannabinoid (bonsai).

Kaynakça

AAPCC (2012) Issues Statement on the Synthetic Drug Abuse Prevention Act. American

Association of Poison Control Centre,6 Kasym 2015'de http://www.aapcc.org/press/2/. adresinden indirilmi?tir.

Akgül A, A?çyo?lu F (2011) Uyu?turucu maddelerde yeni trendler ve erken uyary sistemi, örgütlü suçlar ve yeni trendler Ankara, Turkey : Polis akademisi yayynlary: 29-56.

Aksel G, Bozan Ö, Kayacy M ve ark. (2015) Turkish Journal of Emergency Medicine. http://www.trjemergmed.com/ jvi.aspx?pdir=tatd&plng=eng&un=TATD-80388&look4=.

Alycy T, Uzbay YT (2006) Kannabinoidler: ödüllendirici ve ba?ymlylyk yapycy etkilerinin nörobiyolojisi ve nöropsikofar- makolojisi üzerine bir gözden geçirme. Ba?ymlylyk Dergisi 7: 140-149.

Amerikan Psikiyatri Birli?i (2013a) Mental Bozukluklaryn Tanysal ve Sayymsal Tany Ölçütleri Ba?vuru Elkitaby, Ykinci Basky (DSM-IV-TR) (Çev. ed.: E Köro?lu). Gözden Geçirilmi?. Ankara, Hekimler Yayyn Birli?i.

Amerikan Psikiyatri Birli?i (2013b). Mental Bozukluklaryn Tanysal ve Sayymsal Tany Ölçütleri Ba?vuru Elkitaby, Be?inci Basky (DSM-5) (Çev. ed: E Köro?lu). Ankara, Hekimler Yayyn Birli?i.

Ayhan H, Aslan AN, Süygün H ve ark. (2014) Türk Kardiyol Dern Ar?, 42(6): 560-563.

British Psychological Society (BPS) (2016). Addiction. Psychology Today.

Boone C (2012) Teens Death, 17 Mart 2015'dewww.ajc.com/news/news/local/teens-death-officially- linked-to-synthetic- pot/nQWKk/?__federated=1. adresinden indirilmi?tir.

Castellanos D, Singh S, Thornton G ve ark. (2011). Synthetic cannabinoid use: A case series of adolescents. J Adolesc Health, 49:347-349

Çakycy M, Çakycy E, Karaaziz M ve ark. (2013) Kuzey Kybrys'ta Madde Kullanymynyn Yaygynly?y. Lefko?a, KKTC Devlet Basymevi.

Çakycy M, Çakycy E, Karaaziz M ve ark. (2015) Kuzey Kybrys'ta Madde Kullanymynyn Yaygynly?y. Lefko?a, KKTC Devlet Basymevi.

Ekim M, Ekim H (2016) Sentetik Kannabinoidlerin (Bonzai) Kullanylmasyna Ba?ly Psi?ik ve Kardiyovasküler Rahatsyzlyklar. Typ Ara?tyrmalary Dergisi. 14(1):79-83

Every-Palmer S (2010) Warning: legal synthetic cannabinoid receptor agonists suchlike as JWH-018 feb precipitate psychosis in vulnerable individuals. Addiction, 105:1859-60.

Every-Palmer S (2011) Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend, 1:117:152-7.

EMCDDA-Europol (2008) Annual Report on the Implementation of Council Decision

/387/JHA. Annex 2: New psychoactive substances reported to the EMCDDA and Europol for the first time in 2008 under the terms of Council Decision, 005/387/JHA. 21 Kasym 2015'de http://www.emcdda.europa.eu/attachements.cfm/att_77263_ EN_EMCDDA-Europol_Annual_Report_Art10_2008. pdf.adresinden indirilmi?tir.

EMCDDA (2009) Annual report on the state of the drugs prob- lem in Europe. European

Monitoring Centre for Drugs and Drug Addiction, Lisbon. 19 Kasym 2015'de http://www.emcdda.europa.eu/ attachements.cfm/att_93236_EN_EMCDDA_AR2009_EN.pdf. adresinden indirilmi?tir.

EMCDDA (2010) Annual report on the state of the drugs prob- lem in Europe. European

Monitoring Centre for Drugs and Drug Addiction, Lisbon, 20 Kasym 2015'de

http://www.emcdda.europa.eu/attachements.cfm/att_120104_E N_EMCDDA_AR210_EN.pdf. adresinden indirilmi?tir.

EMCDDA-Europol (2011) Annual Report on the implementa- tion of Council Decision

/387/JHA. 20 Kasym 2015'de http://www.emcdda. europa.eu/attachements.cfm/att_155113_EN_EMCDDA- Europol%20 Annual%20Report%202011_2012_final.pdf. adresinden indirilmi?tir.

Evren C, Bozkurt M. (2013) Sentetik Kannabinoidler, Dü?ünen Adam, 26:1-11.

Evren C (2014) Türkiye Psikiyatri Derne?i, Sentetik Esrar Türevleri (Bonzai) Yle Ylgili

Basyn Açyklamasy 04.09.2014, Ba?ymlylyk Dergisi, 15(4): 57-59.

Fattore L, Fratta W (2011) Beyond, T. H. C.: the new generation of cannabinoid

Neuroscience,5:6066.

Grigoryev A, Savchuk S, Melnik A ve ark. (2011) Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018

choactive components of smoking mixtures. J Chromatogr B Biomed Sci Appl, 879: 1126-136.

and JWH-073, psy- Gunderson E, Haughey H, Alt-Daoud N ve ark. (2012) "Spice" and "K2" herbal highs: A case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict, 21:320.

Hoyte CO, Jacob J, Monte AA ve ark. (2012) A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med, 60:435-8.

Hurst D, Loeffler G, McLay R (2011) Psychosis associated with synthetic cannabinoid agonists: a case series. Am J Psychiatry, 168:1119

Hu X, Primack BA, Barnett TE ve ark. (2011). College students and the use of

K2: An emerging drug of abuse in young persons. Substance Abuse Treatment and Prevention Policy,6:16.

Johnston LD, O'MalleyPM, Bachman JG ve ark. (2012) The rise in teen marijuana use stalls, synthetic marijuana use levels, and use of 'bath salts' is very low. University of Michigan News Service: Ann Arbor, MI. 25 Kasym 2015'de htttp://www.monitor- ingthefuture.org/pressreleases/12drugpr.pdf. adresinden indirilmi?tir.

Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry, 162(8):1403-13.

Kalyoncu AÖ, Ünlü B, Ta?tan U (2014) Gençlerin tehlikeli oyunu: sentetik kannabinoidler (bonzai) üzerine bir gözden geçirme. Ba?ymlylyk Dergisi, 15(3): 150-155.

Küçük E, Küçük Y, Yyldyz Kirazaldy Y (2015). Acil serviste yeni bir tehlike: Sentetik kannabinoidler (Bonzai, Jameika). Genel Typ Derg, 25:18-22

Moosmann B, Kneisel S, Girreser U ve ark. (2012) Separation, and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1Hindol-3yl]-(4-methylnaph- thalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system. Forensic Sci Int, 220: 17-22.

Ögel K, Tamar D, Karaly A ve ark. (1998) Alkol ve Madde Kullanym Bozukluklary El Kitaby. Ystanbul, Amatem, Bakyrköy Ruh ve Sinir Hastalyklary Hastanesi.

Öztürk MO (1994) Ruh Sa?ly?y ve Bozukluklary, Yenilenmi? Be?inci Basky, Ankara, Hekimler Yayyn Birli?i.

Paki? I, Polat O (2016). Sentetik Kannabinoidler. ACU Sa?lyk Bil Derg, (1):6-13

Pertwee RG (1999). Pharmacology of cannabinoid receptor lig- ands. Curr Med Chem, 6:635-64.

Petry NM, Blanco C, Stinchfield R ve ark. (2013) An empirical evaluation of proposed changes for gambling diagnosis in the DSM-5. Addiction, 108(3): 575-581.

Resmi gazete (2013) 2313 sayyly uyu?turucu maddelerin murak- abesi hakkyndaki kanun /Resmi gazete:sayy:27845. 20 Haziran 2016'da http://www.resmigazete.gov. tr/eskil- er/2011/02/20110213-4.htm. adresinden indirilmi?tir.

Seely KA, Lapoint J, Moran JH ve ark. (2012) Spice drugs are more than

cology and toxicology of synthetic cannabinoids.Prog Neuropsychopharmacol Biol Psychiatry, 39: 234-243.

Tellio?lu T, Tellio?lu Z (2012) Tybbi Esrar Psikiyatrik Bozukluklaryn Tedavisinde Kullanylabilir mi ? Klinik Psikofarmakoloji Bülteni, 22(1): 98-109.

Tosun M (2008) Madde ba?ymlyly?yna genel bir baky?. Türkiye'de Syk Kar?yla?ylan

Psikiyatrik Hastaliklar Sempozyum Dizisi, 62(S): 201-220.

Türk Ceza Kanunu (2015) Sentetik Kannabinoid hakkyndaki karar, 20 Haziran 2016'da http://www.tbmm.gov.tr/develop/owa/ Tutanak_B_SD.birlesim_baslangic?P4=22361&P5Hpge1=86& page2=86. adresinden indirilmi?tir.

Türkiye Uyu?turucu Raporu (2013). 28 Aralyk 2015'de http://www.kom.gov.tr/Tr/ Dosyalar/2013_TURKIYE_UYUS- TURUCU_ RAPORU. adresinden indirilmi?tir.

T.C. Cumhurba?kanli?i Devlet Denetleme Kurulu Ara?tyrma ve Ynceleme Raporu,

(2014) Madde ve Di?er Ba?ymlylyklar ile Mücadele Kapasitesinin ve Bu Ba?lamda Türkiye Ye?ilay Cemiyetinin De?erlendirilmesi, 2014/2.

U?urlu T, ?engül C, ?engül C (2012) Ba?ymlyly?yn Psikofarmakolojisi. Psikiyatride

Güncel Yakla?ymlar, 4 (1):37-50.

UNDOC, (2011). Synthetic cannabinoids in herbal products. United Nations

Office on Drugs and Crime, 2011. 20 Haziran 2016'da http://www.unodc.org/documents/scientific/Synthetic_Cannabin oids.pdf. adresinden indirilmi?tir.

Uzbay YT (2009) Ba?ymlylyk yapan maddeler ve özellikleri. MYSED (Türk Eczacylary

Birli?i Meslek Yçi Sürekli E?itim Dergisi), Aralyk (21-22): 16-33. Uzbay YT, Yüksel N (2003) Madde kötüye kullanymy ve ba?ym- lyly?y. Psikofarmakoloji. (Ed.:N. Yüksel), Yenilenmi? Ykinci Basky, Ankara, Çizgi Typ Kitabevi, s.485-520.

World Health Organization (WHO) (2016) Remarks at the UN General Assembly Special Session on the World Drug Problem, Speech of Dr Margaret Chan, Director-General of the World Health Organization (19 April 2016), New York, USA. 20 Haziran 2016'da http://www.who.int/dg/speeches/2016/world- drug-problem/en/ adresinden indirilmi?tir.

Kaynak Göster